| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Karen S Rommelfanger, Thomas Wichman. Extrastriatal dopaminergic circuits of the Basal Ganglia. Frontiers in neuroanatomy. vol 4. 2011-07-14. PMID:21103009. |
however, recent evidence suggests that dopamine may also modulate basal ganglia function at sites outside of the striatum, and that changes in dopaminergic transmission at these sites may contribute to the symptoms of pd and other neuropsychiatric disorders. |
2011-07-14 |
2023-08-12 |
Not clear |
| Karen S Rommelfanger, Thomas Wichman. Extrastriatal dopaminergic circuits of the Basal Ganglia. Frontiers in neuroanatomy. vol 4. 2011-07-14. PMID:21103009. |
further insights into the dopaminergic modulation of basal ganglia function at extrastriatal sites may provide us with opportunities to develop new and more specific strategies for treating disorders of basal ganglia dysfunction. |
2011-07-14 |
2023-08-12 |
Not clear |
| Rajesh P N Ra. Decision making under uncertainty: a neural model based on partially observable markov decision processes. Frontiers in computational neuroscience. vol 4. 2011-07-14. PMID:21152255. |
additionally, the time course of reward prediction error in the model shares similarities with dopaminergic responses in the basal ganglia during the random dots task. |
2011-07-14 |
2023-08-12 |
Not clear |
| Paola Bonsi, Dario Cuomo, Giuseppina Martella, Graziella Madeo, Tommaso Schirinzi, Francesca Puglisi, Giulia Ponterio, Antonio Pisan. Centrality of striatal cholinergic transmission in Basal Ganglia function. Frontiers in neuroanatomy. vol 5. 2011-07-14. PMID:21344017. |
loss of the reciprocal modulation between dopaminergic inputs and the intrinsic cholinergic innervation within the striatum appears to be the trigger for pathophysiological changes occurring in basal ganglia disorders. |
2011-07-14 |
2023-08-12 |
Not clear |
| Alberta Latteri, Paolo Arena, Paolo Mazzon. Characterizing Deep Brain Stimulation effects in computationally efficient neural network models. Nonlinear biomedical physics. vol 5. issue 1. 2011-07-14. PMID:21496222. |
this technique, frequently joined to dopaminergic drugs administration, replaces the surgical interventions implemented to contrast the activity of specific brain nuclei, called basal ganglia (bg). |
2011-07-14 |
2023-08-12 |
Not clear |
| Melissa L Perreault, Ahmed Hasbi, Brian F O'Dowd, Susan R Georg. The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia. Frontiers in neuroanatomy. vol 5. 2011-07-14. PMID:21747759. |
dopaminergic signaling within the basal ganglia has classically been thought to occur within two distinct neuronal pathways; the direct striatonigral pathway which contains the dopamine d1 receptor and the neuropeptides dynorphin (dyn) and substance p, and the indirect striatopallidal pathway which expresses the dopamine d2 receptor and enkephalin (enk). |
2011-07-14 |
2023-08-12 |
Not clear |
| Marc J Lanova. Towards a comprehensive model of stereotypy: integrating operant and neurobiological interpretations. Research in developmental disabilities. vol 32. issue 2. 2011-06-14. PMID:21236636. |
the dopaminergic system and the basal ganglia are both involved in stereotypy and in reinforcement, which provides a potential link between the models. |
2011-06-14 |
2023-08-12 |
Not clear |
| Mario E Alburges, Amanda J Hoonakker, Kristen A Horner, Annette E Fleckenstein, Glen R Hanso. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment. Journal of neurochemistry. vol 117. issue 3. 2011-06-10. PMID:21323925. |
methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment. |
2011-06-10 |
2023-08-12 |
rat |
| S R Criswell, J S Perlmutter, T O Videen, S M Moerlein, H P Flores, A M Birke, B A Racett. Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology. vol 76. issue 15. 2011-06-07. PMID:21471467. |
welding exposes workers to manganese (mn) fumes, but it is unclear if this exposure damages dopaminergic neurons in the basal ganglia and predisposes individuals to develop parkinsonism. |
2011-06-07 |
2023-08-12 |
Not clear |
| Esther Fujimoto, Tamara J Stevenson, Chi-Bin Chien, Joshua L Bonkowsk. Identification of a dopaminergic enhancer indicates complexity in vertebrate dopamine neuron phenotype specification. Developmental biology. vol 352. issue 2. 2011-05-26. PMID:21276790. |
the dopaminergic neurons of the basal ganglia play critical roles in cns function and human disease, but specification of dopamine neuron phenotype is poorly understood in vertebrates. |
2011-05-26 |
2023-08-12 |
mouse |
| Adarsh M Kumar, Raymond L Ownby, Drenna Waldrop-Valverde, Benny Fernandez, Mahendra Kuma. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. Journal of neurovirology. vol 17. issue 1. 2011-05-12. PMID:21165787. |
hiv-1 enters the brain soon after the initial infection and is distributed in varying concentrations in different regions with specific affinity to the subcortical regions, particularly the basal ganglia, causing neurodegeneration of dopaminergic regions and resulting in the decreased availability of dopamine (da) in the cns. |
2011-05-12 |
2023-08-12 |
human |
| Rita Willemssen, Michael Falkenstein, Michael Schwarz, Thomas Müller, Christian Best. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control. Neurobiology of aging. vol 32. issue 2. 2011-03-30. PMID:19269061. |
the results suggest that compatible and incompatible s-r relations demand different neuronal mechanisms within the basal ganglia, as only the former are affected by agonizing the dopaminergic system. |
2011-03-30 |
2023-08-12 |
human |
| S K Kalia, L V Kalia, P J McLea. Molecular chaperones as rational drug targets for Parkinson's disease therapeutics. CNS & neurological disorders drug targets. vol 9. issue 6. 2011-02-28. PMID:20942788. |
parkinson's disease is a neurodegenerative movement disorder that is caused, in part, by the loss of dopaminergic neurons within the substantia nigra pars compacta of the basal ganglia. |
2011-02-28 |
2023-08-12 |
Not clear |
| Begoña Villar-Cheda, Jannette Rodríguez-Pallares, Rita Valenzuela, Ana Muñoz, Maria J Guerra, Ovidiu C Baltatu, Jose L Labandeira-Garci. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease. The European journal of neuroscience. vol 32. issue 10. 2011-02-28. PMID:20964730. |
the basal ganglia have a local renin-angiotensin system and it has been shown that the loss of dopaminergic neurons induced by neurotoxins is amplified by local angiotensin ii (aii) via angiotensin type 1 receptors (at1) and nicotinamide adenine dinucleotide phosphate (nadph) complex activation. |
2011-02-28 |
2023-08-12 |
mouse |
| Begoña Villar-Cheda, Jannette Rodríguez-Pallares, Rita Valenzuela, Ana Muñoz, Maria J Guerra, Ovidiu C Baltatu, Jose L Labandeira-Garci. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease. The European journal of neuroscience. vol 32. issue 10. 2011-02-28. PMID:20964730. |
the results reveal an important interaction between the dopaminergic and local renin-angiotensin system in the basal ganglia, which may be a major factor in the progression of parkinson's disease. |
2011-02-28 |
2023-08-12 |
mouse |
| Richard Kone. Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. vol 25. issue 4. 2011-02-17. PMID:20702843. |
pathological hallmarks of parkinson's disease are destruction of dopaminergic neurons in the basal ganglia, especially the substantia nigra, and the presence of lewy bodies within nerve cells. |
2011-02-17 |
2023-08-12 |
Not clear |
| Carol A Seger, Earl K Mille. Category learning in the brain. Annual review of neuroscience. vol 33. 2011-01-27. PMID:20572771. |
it is subserved by plasticity in many neural systems, including neocortical regions (sensory, prefrontal, parietal, and motor cortex), the medial temporal lobe, the basal ganglia, and midbrain dopaminergic systems. |
2011-01-27 |
2023-08-12 |
Not clear |
| Marta Moraschi, Giovanni Giulietti, Federico Giove, Manuela Guardati, Girolamo Garreffa, Nicola Modugno, Claudio Colonnese, Bruno Maravigli. fMRI study of motor cortex activity modulation in early Parkinson's disease. Magnetic resonance imaging. vol 28. issue 8. 2011-01-12. PMID:20423753. |
parkinson's disease is a neurological disorder associated with the disfunction of dopaminergic pathways of the basal ganglia, mainly resulting in a progressive alteration in the execution of voluntary movements. |
2011-01-12 |
2023-08-12 |
human |
| Ron Levy, Andres M Lozano, Anthony E Lang, Jonathan O Dostrovsk. Event-related desynchronization of motor cortical oscillations in patients with multiple system atrophy. Experimental brain research. vol 206. issue 1. 2010-12-28. PMID:20821197. |
the findings suggest that cortical activation in patients with msa is diminished, may be related to pathophysiological changes occurring in the basal ganglia and correlates with the poor clinical response that these patients typically obtain with dopaminergic therapy. |
2010-12-28 |
2023-08-12 |
human |
| Christelle Baunez, Paolo Gubellin. Effects of GPi and STN inactivation on physiological, motor, cognitive and motivational processes in animal models of Parkinson's disease. Progress in brain research. vol 183. 2010-12-27. PMID:20696323. |
loss of the dopaminergic input to the striatum, characterizing parkinson's disease, leads to the hyper-activity of two key nuclei of the basal ganglia (bg): the subthalamic nucleus (stn) and the internal segment of the globus pallidus (gpi). |
2010-12-27 |
2023-08-12 |
Not clear |